Viewing Study NCT04300959


Ignite Creation Date: 2025-12-24 @ 2:39 PM
Ignite Modification Date: 2025-12-26 @ 8:26 AM
Study NCT ID: NCT04300959
Status: UNKNOWN
Last Update Posted: 2020-03-09
First Post: 2020-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module